Yu B - Search Results

1

New Classification of Macrophages in Plaques: a Revolution.

Deng H, Sun Y, Zeng W, Li H, Guo M, Yang L, Lu B, Yu B, Fan G, Gao Q, Jiang X. Deng H, et al. Among authors: yu b. Curr Atheroscler Rep. 2020 Jun 18;22(8):31. doi: 10.1007/s11883-020-00850-y. Curr Atheroscler Rep. 2020. PMID: 32556603 Review.

2

The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.

Zeng W, Wu D, Sun Y, Suo Y, Yu Q, Zeng M, Gao Q, Yu B, Jiang X, Wang Y. Zeng W, et al. Among authors: yu q, yu b. Sci Rep. 2021 Sep 29;11(1):19305. doi: 10.1038/s41598-021-98437-3. Sci Rep. 2021. PMID: 34588488 Free PMC article.

3

Roles of Gut Microbiota in Pathogenesis of Alzheimer's Disease and Therapeutic Effects of Chinese Medicine.

Sun YX, Jiang XJ, Lu B, Gao Q, Chen YF, Wu DB, Zeng WY, Yang L, Li HH, Yu B. Sun YX, et al. Among authors: yu b. Chin J Integr Med. 2022 Nov;28(11):1048-1056. doi: 10.1007/s11655-020-3274-5. Epub 2020 Sep 1. Chin J Integr Med. 2022. PMID: 32876860 Review.

4

Sodium danshensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1.

Gao Q, Deng H, Yang Z, Yang Q, Zhang Y, Yuan X, Zeng M, Guo M, Zeng W, Jiang X, Yu B. Gao Q, et al. Among authors: yu b. Front Pharmacol. 2022 Sep 15;13:946668. doi: 10.3389/fphar.2022.946668. eCollection 2022. Front Pharmacol. 2022. PMID: 36188542 Free PMC article.

5

Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review.

Wu D, Chen Y, Sun Y, Gao Q, Li H, Yang Z, Wang Y, Jiang X, Yu B. Wu D, et al. Among authors: yu b. Inflammation. 2020 Feb;43(1):17-23. doi: 10.1007/s10753-019-01098-8. Inflammation. 2020. PMID: 31646445 Review.

6

Gasdermin family: a promising therapeutic target for cancers and inflammation-driven diseases.

Wu D, Chen Y, Sun Y, Gao Q, Yu B, Jiang X, Guo M. Wu D, et al. Among authors: yu b. J Cell Commun Signal. 2020 Sep;14(3):293-301. doi: 10.1007/s12079-020-00564-5. Epub 2020 Mar 31. J Cell Commun Signal. 2020. PMID: 32236886 Free PMC article. Review.

7

Effectiveness of Combined Thrombolysis and Mild Hypothermia Therapy in Acute Cerebral Infarction: A Meta-Analysis.

Guo L, Bu H, Guo M, Zhang Y, Yu Q, Yu B, Jiang X, Yang L. Guo L, et al. Among authors: yu q, yu b. Evid Based Complement Alternat Med. 2022 Apr 16;2022:4044826. doi: 10.1155/2022/4044826. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35469165 Free PMC article. Review.

8

Pharmacological therapy to cerebral ischemia-reperfusion injury: Focus on saponins.

Zeng M, Zhang R, Yang Q, Guo L, Zhang X, Yu B, Gan J, Yang Z, Li H, Wang Y, Jiang X, Lu B. Zeng M, et al. Among authors: yu b. Biomed Pharmacother. 2022 Nov;155:113696. doi: 10.1016/j.biopha.2022.113696. Epub 2022 Sep 16. Biomed Pharmacother. 2022. PMID: 36116247 Free article. Review.

9

Cardioprotection of ginsenoside Rb1 against ischemia/reperfusion injury is associated with mitochondrial permeability transition pore opening inhibition.

Li YH, Li YY, Fan GW, Yu JH, Duan ZZ, Wang LY, Yu B. Li YH, et al. Among authors: yu b, yu jh. Chin J Integr Med. 2016 Jan 6. doi: 10.1007/s11655-015-2433-6. Online ahead of print. Chin J Integr Med. 2016. PMID: 26740222

10

Danhong injection protects cardiomyocytes against hypoxia/reoxygenation- and H2O2-induced injury by inhibiting mitochondrial permeability transition pore opening.

Duan ZZ, Li YH, Li YY, Fan GW, Chang YX, Yu B, Gao XM. Duan ZZ, et al. Among authors: yu b. J Ethnopharmacol. 2015 Dec 4;175:617-25. doi: 10.1016/j.jep.2015.08.033. Epub 2015 Aug 29. J Ethnopharmacol. 2015. PMID: 26320687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,275 results

Search Page

Filters